🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Massachusetts › Worcester

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Worcester, MA

14 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Worcester (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • UMass Memorial Medical Center - University Campus, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Mengambil pesertaFasa 3
  • University of Massachusetts Memorial Medical Center, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06472245

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • UMass Memorial Medical Center - University Campus, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • University of Massachusetts Worcester, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07144280

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Reliant Medical Group, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06890598

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Mengambil pesertaFasa 3
  • Clinical Study Site, Worcester
  • Clinical Study Site, Milford · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Mengambil pesertaFasa 2/3
  • Dana-Farber Brigham and Womens Cancer Center at Milford Regional, Milford · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04613596

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • UMass Memorial Medical Center - University Campus, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • UMass Memorial Medical Center - University Campus, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • UMass Memorial Medical Center - University Campus, Worcester
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • UMass Memorial Medical Center - University Campus, Worcester
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Worcester
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Worcester

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.